Advertisement
Review Article| Volume 20, ISSUE 4, P661-677, October 2004

Pulmonary embolism and pregnancy

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Prevention of venous thrombosis and pulmonary embolism: NIH Consensus Development.
        JAMA. 1986; 256: 744-749
        • Gherman R.B.
        • Goodwin T.M.
        • Leung B.
        • Byrne J.D.
        • Hethumumi R.
        • Montoro M.
        Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy.
        Obstet Gynecol. 1999; 94: 730-734
        • Refuerzo J.S.
        • Hechtman J.L.
        • Redman M.E.
        • Whitty J.E.
        Venous thromboembolism during pregnancy: clinical suspicion warrants evaluation.
        J Reprod Med Oct. 2003; 48: 767-770
        • Andersen B.S.
        • Steffensen F.H.
        • Sorensen H.T.
        • Nielsen G.L.
        • Olsen J.
        The cumulative incidence of venous thromboembolism during pregnancy and puerperium–an 11 year Danish population-based study of 63,300 pregnancies.
        Acta Obstet Gynecol Scand. 1998; 77: 170-173
        • Callaghan W.M.
        • Berg C.J.
        Pregnancy-related mortality among women aged 35 years and older, United States, 1991–1997.
        Obstet Gynecol. 2003; 102: 1015-1021
        • Atrash H.K.
        • Koonin L.M.
        • Lawson H.W.
        • Franks A.L.
        • Smith J.C.
        Maternal mortality in the United States, 1979–1986.
        Obstet Gynecol. 1990; 76: 1055-1060
        • Jacob S.
        • Bloebaum L.
        • Shah G.
        • Varner M.W.
        Maternal mortality in Utah.
        Obstet Gynecol. 1998; 91: 187-191
        • Sachs B.P.
        • Brown D.A.
        • Driscoll S.G.
        • Schulman E.
        • Acker D.
        • Ransil B.J.
        • et al.
        Maternal mortality in Massachusetts: trends and prevention.
        N Engl J Med. 1987; 316: 667-672
        • Choi H.S.
        • Han S.S.
        • Choi H.A.
        • Kim H.S.
        • Lee C.G.
        • Kim Y.Y.
        • et al.
        Dyspnea and palpitation during pregnancy.
        Korean J Intern Med Dec. 2001; 16: 247-249
        • Garcia-Rio F.
        • Pino J.M.
        • Gomez L.
        • Alvarez-Sala R.
        • Villasante C.
        • Villamor J.
        Regulation of breathing and perception of dyspnea in healthy pregnant women.
        Chest. 1996; 110: 446-453
        • Toglia M.R.
        • Weg J.G.
        Venous thromboembolism during pregnancy.
        N Engl J Med. 1996; 335: 108-114
        • Ray J.G.
        • Chan W.S.
        Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation.
        Obstet Gynecol Surv. 1999; 54: 265-271
        • Ginsberg J.S.
        • Brill-Edwards P.
        • Burrows R.F.
        • Bona R.
        • Pradoni P.
        • Buller H.R.
        • et al.
        Venous thrombosis during pregnancy: leg and trimester of presentation.
        Thromb Haemost. 1992; 67: 519-520
        • Greer I.A.
        The special case of venous thromboembolism in pregnancy.
        Haemostasis. 1998; 28: 22-34
        • Rutherford S.E.
        • Phelan J.P.
        Deep venous thrombosis and pulmonary embolism in pregnancy.
        Obstet Gynecol Clin North Am. 1991; 18: 345-370
        • Winer-Muram H.T.
        • Boone J.M.
        • Brown H.L.
        • Jennings S.G.
        • Mabie W.C.
        • Lombardo G.T.
        Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT.
        Radiology. 2002; 224: 487-492
        • Clark P.
        • Brennand J.
        • Conkie J.A.
        • McCall F.
        • Greer I.A.
        • Walker I.D.
        Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy.
        Thrombosis and Haemostasis. 1998; 79: 1166-1170
        • Pabinger I.
        • Grafenhofer H.
        Thrombosis during pregnancy: risk factors, diagnosis and treatment.
        Pathophysiol Haemost Thromb. 2002; 32: 322-324
        • Milne J.A.
        • Howie A.D.
        • Pack A.I.
        Dyspnoea during normal pregnancy.
        Br J Obstet Gynaecol. 1978; 85: 260-263
        • Chan W.S.
        • Ginsberg J.S.
        Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy.
        Thromb Res. 2002; 107: 85-91
        • Ginsberg J.S.
        • Hirsh J.
        • Rainbow A.J.
        • Coates G.
        Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease.
        Thromb Haemost. 1989; 61: 189-196
        • Kearon C.
        • Julian J.A.
        • Newman T.E.
        • Ginsberg J.S.
        Noninvasive diagnosis of deep venous thrombosis: McMaster Diagnostic Imaging Practice Guidelines Initiative [see comments].
        Ann Intern Med. 1998; 128: 663-677
        • Heijboer H.
        • Beuller H.R.
        • Lensing A.W.
        • Turpie A.G.
        • Colly L.P.
        • ten Cate J.W.
        A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients [see comments].
        N Engl J Med. 1993; 329: 1365-1369
        • Prandoni P.
        • Mannucci P.M.
        Deep-vein thrombosis of the lower limbs: diagnosis and management.
        Baillieres Best Pract Res Clin Haematol. 1999; 12: 533-554
        • de Boer K.
        • Buller H.R.
        • ten Cate J.W.
        • Levi M.
        Deep vein thrombosis in obstetric patients: diagnosis and risk factors.
        Thromb Haemost. 1992; 67: 4-7
        • Brown M.D.
        • Rowe B.H.
        • Reeves M.J.
        • Bermingham J.M.
        • Goldhaber S.Z.
        The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: a meta-analysis.
        Ann Emerg Med. 2002; 40: 133-144
        • Fedullo P.F.
        • Tapson V.F.
        Clinical practice: the evaluation of suspected pulmonary embolism.
        N Engl J Med. 2003; 349: 1247-1256
        • Nolan T.E.
        • Smith R.P.
        • Devoe L.D.
        Maternal plasma D-dimer levels in normal and complicated pregnancies.
        Obstet Gynecol. 1993; 81: 235-238
        • The PIOPED Investigators
        Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism diagnosis (PIOPED) [see comments].
        JAMA. 1990; 263: 2753-2759
        • Meaney J.F.
        • Weg J.G.
        • Chenevert T.L.
        • Stafford-Johnson D.
        • Hamilton B.H.
        • Prince M.R.
        Diagnosis of pulmonary embolism with magnetic resonance angiography.
        N Engl J Med. 1997; 336: 1422-1427
        • Mullins M.D.
        • Becker D.M.
        • Hagspiel K.D.
        • Philbrick J.T.
        The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism.
        Arch Intern Med. 2000; 160: 293-298
        • Rathbun S.W.
        • Raskob G.E.
        • Whitsett T.L.
        Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review [see comments].
        Ann Intern Med. 2000; 132: 227-232
        • Hiorns M.P.
        • Mayo J.R.
        Spiral computed tomography for acute pulmonary embolism.
        Can Assoc Radiol J. 2002; 53: 258-268
        • Goodman L.R.
        • Curtin J.J.
        • Mewissen M.W.
        • Foley W.D.
        • Lipchik R.J.
        • Crain M.R.
        • et al.
        Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography.
        AJR Am J Roentgenol. 1995; 164: 1369-1374
        • Levine D.
        • Barnes P.D.
        • Edelman R.
        Obstetric MR imaging.
        Radiology. 1999; 211: 609-617
        • Marcos H.B.
        • Semelka R.C.
        • Worawattanakul S.
        Normal placenta: gadolinium-enhanced dynamic MR imaging.
        Radiology. 1997; 205: 493-496
        • Ginsberg J.S.
        • Bates S.M.
        Management of venous thromboembolism during pregnancy.
        J Thromb Haemost. 2003; 1: 1435-1442
        • Ginsberg J.S.
        • Hirsh J.
        • Turner D.C.
        • Levine M.N.
        • Burrows R.
        Risks to the fetus of anticoagulant therapy during pregnancy.
        Thromb Haemost. 1989; 61: 197-203
        • Pravinkumar E.
        • Webster N.R.
        HIT/HITT and alternative anticoagulation: current concepts.
        Br J Anaesth. 2003; 90: 676-685
        • Warkentin T.E.
        • Levine M.N.
        • Hirsh J.
        • Horsewood P.
        • Roberts R.S.
        • Gent M.
        • et al.
        Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin [see comments].
        N Engl J Med. 1995; 332: 1330-1335
        • Ginsberg J.S.
        • Greer I.
        • Hirsh J.
        Use of antithrombotic agents during pregnancy.
        Chest. 2001; 119: 122S-131S
        • Dolovich L.R.
        • Ginsberg J.S.
        • Dpiletos J.D.
        • Holbrook A.M.
        • Cheah G.
        A meta-analysis comparing low-molecular-weight heparin with unfractionated heparin in the treatment of venous thromboembolism.
        Arch Intern Med. 2000; 160: 181-188
        • Lindhoff-Last E.
        • Nakov R.
        • Misselwitz F.
        • Breddin H.K.
        • Bauersachs R.
        Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin.
        Br J Haematol. 2002; 118: 1137-1142
        • Haram K.
        • Hervig T.
        • Thordarson H.
        • Aksnes L.
        Osteopenia caused by heparin treatment in pregnancy.
        Acta Obstet Gynecol Scand. 1993; 72: 674-675
        • Aarskog D.
        • Aksnes L.
        • Markestad T.
        • Ulstein M.
        • Sagen N.
        Heparin-induced inhibition of 1,25-dihydroxyvitamin D formation.
        Am J Obstet Gynecol. 1984; 148: 1141-1142
        • von Mach U.
        • Aebersold F.
        • Huch R.
        • Huch A.
        Short-term low-dose heparin plus bedrest impairs bone metabolism in pregnant women.
        Eur J Obstet Gynecol Reprod Biol. 2003; 106: 25-30
        • Barbour L.A.
        • Kick S.D.
        • Steiner J.F.
        • et al.
        A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry.
        Am J Obstet Gynecol. 1994; 170: 862-869
        • Shefras J.
        • Farquharson R.G.
        Bone density studies in pregnant women receiving heparin.
        Eur J Obstet Gynecol Reprod Biol. 1996; 65: 171-174
        • Backos M.
        • Rai R.
        • Thomas E.
        • Murphy M.
        • Dore C.
        • Regan L.
        Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study.
        Hum Reprod. 1999; 14: 2876-2880
        • Ginsberg J.S.
        • Chan W.S.
        • Bates S.M.
        • Kaatz S.
        Anticoagulation of pregnant women with mechanical heart valves.
        Arch Intern Med. 2003; 163: 694-698
        • Sanson B.J.
        • Lensing A.W.
        • Prins M.H.
        • Ginsberg J.S.
        • Barkagan Z.S.
        • Lavenne-Pardonge E.
        • et al.
        Safety of low-molecular-weight heparin in pregnancy: a systematic review.
        Thromb Haemost. 1999; 81: 668-672
        • Bates S.M.
        • Weitz J.I.
        • Johnston M.
        • Hirsh J.
        • Ginsberg J.S.
        Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin.
        Arch Intern Med. 2001; 161: 385-391
        • Barbour L.A.
        • Smith J.M.
        • Marlar R.A.
        Heparin levels to guide thromboembolism prophylaxis during pregnancy.
        Am J Obstet Gynecol. 1995; 173: 1869-1873
        • Jacobsen A.F.
        • Qvigstad E.
        • Sandset P.M.
        Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy.
        British Journal of Obstetrics and Gynaecology. 2003; 110: 139-144
        • Buller H.R.
        • Davidson B.L.
        • Decousus H.
        • Gallus A.
        • Gent M.
        • Riovella F.
        • et al.
        Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
        N Engl J Med. 2003; 349: 1695-1702
        • Schulman S.
        • Wahlander K.
        • Lundstrom T.
        • Clason S.B.
        • Eriksson H.
        Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.
        N Engl J Med. 2003; 349: 1713-1721
        • Greer I.A.
        • Thomson A.J.
        Management of venous thromboembolism in pregnancy.
        Best Pract Res Clin Obstet Gynaecol. 2001; 15: 583-603
        • Greer I.A.
        Thrombosis in pregnancy: maternal and fetal issues.
        Lancet. 1999; 353: 1258-1265
        • Clark S.L.
        • Porter T.F.
        • West F.G.
        Coumarin derivatives and breast-feeding.
        Obstet Gynecol. 2000; 95: 938-940
        • Kearon C.
        • Gent M.
        • Hirsh J.
        • Weitz J.
        • Kovacs M.J.
        • Anderson D.R.
        • et al.
        A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism [see comments].
        N Engl J Med. 1999; 340: 901-907
        • Agnelli G.
        • Prandoni P.
        • Santamaria M.G.
        • Bagatella P.
        • Iono A.
        • Bazzan M.
        • et al.
        Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis: Warfarin Optimal Duration Italian Trial Investigators.
        N Engl J Med. 2001; 345: 165-169
        • Schulman S.
        • Rhedin A.S.
        A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism.
        N Engl J Med. 1995; 332: 1661-1665
        • Schulman S.
        • Granqvist S.
        • Holmstrom M.
        • Carlsson A.
        • Lindmarker P.
        • Nicol P.
        • et al.
        The duration of oral anticoagulant therapy after a second episode of venous thromboembolism: the Duration of Anticoagulation Trial Study Group [see comments].
        N Engl J Med. 1997; 336: 393-398
        • Ridker P.M.
        • Goldhaber S.Z.
        • Danielson E.
        • Rosenberg Y.
        • Eby C.S.
        • Deitcher S.R.
        • et al.
        Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
        N Engl J Med. 2003; 348: 1425-1434
        • Linkins L.A.
        • Choi P.T.
        • Douketis J.D.
        Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
        Ann Intern Med. 2003; 139: 893-900
        • Levinson G.
        • Shnider S.M.
        Vasopressors in obstetrics.
        Anesth Clin. 1974; 10: 77-109
        • Mabie W.C.
        • Barton J.R.
        • Sibai B.
        Septic shock in pregnancy.
        Obstet Gynecol. 1997; 90: 553-561
        • Hyers T.M.
        • Agnelli G.
        • Hull R.D.
        • Morris T.A.
        • Samama M.
        • Tapson V.
        • et al.
        Antithrombotic therapy for venous thromboembolic disease.
        Chest. 2001; 119: 176S-193S
        • Ahearn G.S.
        • Hadjiliadis D.
        • Govert J.A.
        • Tapson V.F.
        Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options.
        Arch Intern Med. 2002; 162: 1221-1227
        • Huang W.H.
        • Kirz D.S.
        • Gallee R.C.
        • Gordey K.
        First trimester use of recombinant tissue plasminogen activator in pulmonary embolism.
        Obstet Gynecol. 2000; 96: 838
        • Kramer W.B.
        • Belfort M.
        • Saade G.R.
        • Surani S.
        • Moise Jr, K.J.
        Successful urokinase treatment of massive pulmonary embolism in pregnancy.
        Obstet Gynecol. 1995; 86: 660-662
        • Saviotti M.
        • Bongarzoni A.
        • Casazza F.
        [Massive pulmonary embolism during the third trimester of pregnancy: effectiveness of thrombolytic treatment with alteplase].
        G Ital Cardiol. 1997; 27: 72-75
        • Arcasoy S.M.
        • Kreit J.W.
        Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence.
        Chest. 1999; 115: 1695-1707
        • Konstantinides S.
        • Geibel A.
        • Heusel G.
        • Heinrich F.
        • Kasper W.
        Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.
        N Engl J Med. 2002; 347: 1143-1150
        • Riedel M.
        Acute pulmonary embolism 2: treatment.
        Heart. 2001; 85: 351-360